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Introduction {#sec1}
============

Cells that can differentiate into all adult cell types exist transiently in early embryos. When cultured in vitro, these pluripotent embryonic stem cells (ESCs) can self-renew indefinitely ([@bib14; @bib28]). Pluripotent, self-renewing cell lines, called induced pluripotent stem cells (iPSCs), can also be derived from somatic cells by transient ectopic expression of transcription factors that are normally expressed in ESCs ([@bib49]). The pluripotent state can be maintained in vitro by defined cytokines such as LIF ([@bib47; @bib51]) and BMP4 or serum ([@bib53]) for mouse pluripotent cells. In particular, removal of LIF leads to spontaneous differentiation of mouse ESCs toward mesoderm and endoderm ([@bib53]).

The class V Pou (PouV) transcription factor Oct4 is central to both the generation and the maintenance of iPSCs and ESCs. Thus, removal of Oct 4 from ESCs causes these cells to differentiate into trophectoderm and primitive endoderm ([@bib17; @bib33; @bib34]), and of the original four factors that together enable iPSC formation, (Oct4, Klf4, Sox2, and c-Myc) ([@bib49]), only Oct4 is essential regardless of the source of somatic cell ([@bib22]). In mouse embryos, Oct4 is initially expressed in the inner cell mass (ICM) of the blastocyst but persists in the pluripotent epiblast and becomes progressively restricted to the posterior region of the embryo, where progenitor cells remain throughout gastrulation ([@bib37]). Oct4^−/−^ embryos die at preimplantation stages as a result of the differentiation of pluripotent ICM progenitors to trophectoderm ([@bib31]). Oct4 homologs in nonmammalian species are also expressed in gastrulation-stage progenitors, where they act to block precocious differentiation ([@bib8; @bib23; @bib27; @bib29; @bib43]). The *Xenopus laevis* PouV protein, Xlpou91, can support murine ESC self-renewal of Oct4 null cells, and *Oct4* mRNA can rescue some *Xenopus* PouV knockdown phenotypes ([@bib29]). What gene-regulatory mechanisms are required to establish and maintain ESCs and iPSCs, and in particular, what role is played by Oct4?

Despite an abundance of data on Oct4 targets and phenotypes, it is still unclear how Oct4 acts as a transcription factor to regulate differentiation. Experiments with reporter genes in cell lines suggest that Oct4 can function as both an activator and a repressor of gene transcription (reviewed in [@bib38]), and Oct4 has been found to be associated with both activator and repressor complexes ([@bib1; @bib3; @bib5; @bib40; @bib41; @bib52; @bib55]).

Genome-wide chromatin immunoprecipitation (ChIP) experiments, with both human and mouse ESCs, have detected Oct4 bound to numerous genes, some of which are expressed in ESCs and some of which are not ([@bib4; @bib12; @bib21; @bib26]). Some of these genes become upregulated, and some downregulated, as ESCs differentiate in response to Oct4 knockdown ([@bib46]) ([@bib26]). This finding has led to the suggestion that, in ESCs, Oct4/PouV and its partners Sox2 and Nanog simultaneously activate genes encoding components of a "pluripotency network" and, simultaneously, repress differentiation-specific genes ([@bib3; @bib4; @bib5; @bib12; @bib21; @bib26; @bib41]). A contrasting suggestion is that Oct4 drives the expression of genes required for differentiation (and not for pluripotency) but this pathway is somehow blocked in ESCs by the conflicting effects of other genes (e.g., Nanog, Klf4, etc.) that attempt to promote differentiation along different pathways ([@bib25]). One line of evidence purported to support this idea is that overexpression of Oct4, like its removal, causes ESCs to differentiate ([@bib34]).

Here, we study Oct4 derivatives designed to act exclusively as activators or repressors of transcription. Each protein bears the PouV DNA-recognition sequence fused to either a strong transcriptional activation region (VP16 and derivatives thereof) or a strong repression region (Engrailed or HP1). We find that the activator, but not the repressor, fusions (along with other transcription factors) drive iPSC formation. The activator fusions, but not the repressor fusions, maintain the growth and pluripotency of murine ESCs lacking wild-type Oct4, and the activator fusions uniquely block differentiation of multipotent progenitor cells in *Xenopus* embryos. While maintaining ESCs in place of Oct4, an Oct4-activator fusion can render the pluripotent state both LIF-independent and immune to an "overexpression" phenotype (apparently by strongly activating key genes). We suggest that the activity of Oct4 as an activator is sufficient for the induction of iPSC formation and the maintenance of ESCs and embryonic progenitors.

Results {#sec2}
=======

Converting PouV Proteins to Activators and Repressors {#sec2.1}
-----------------------------------------------------

[Table 1](#tbl1){ref-type="table"} shows a series of fusion proteins, each with the DNA-binding specificity of Oct4 or Xlpou91, designed to work exclusively as activators or as repressors. Genes encoding these proteins were constructed by fusing intact murine and human Oct4 and Xlpou91 sequences, separately, to an activating region derived from mammalian VP16; to the repressing region of the *Drosophila* protein Engrailed (EnR); and to the mammalian heterochromatin protein HP1. In some cases the flexible hinge region of lambda C1 was interposed between the PouV protein and attached regulatory regions, an approach that has been particularly effective at converting full-length homeodomain repressors to activators ([@bib7; @bib6; @bib56]). As a control, we also made fusions in which the DNA-binding domain was damaged by the mutation V267P ([@bib35]). We tested the activities of these fusion proteins with reporters introduced into the previously described murine ESC line ZHBTc4 ([@bib34]). Both endogenous copies of Oct4 have been deleted from these cells, and an Oct4 transgene, under control of a tetracycline (Tc)-repressible promoter, has been added. The cells grow as ESCs in the absence of Tc, and addition of Tc causes them to differentiate into trophoblast and primitive endoderm cells. In the absence of Tc, an introduced reporter gene bearing Oct4 binding sites is expressed, but by 24 hr after the addition of Tc, the introduced reporter fails to be expressed. mRNA and protein measurements confirm that the added Oct4 gene was essentially silent at this time. Within 96 hr after the addition of Tc, the cells have differentiated ([@bib29; @bib35; @bib34]).

We cotransfected ZHBTc4 ESCs 24 hr after the addition of Tc with, separately, one of two different Oct4 responsive reporter genes ([@bib35]) and one or another of the Pou proteins listed in [Table 1](#tbl1){ref-type="table"}. One reporter contains the Oct4- and Sox2-dependent enhancer of the *Fgf4* gene driving the TK promoter, and the other reporter contains six copies of a reiterated octamer-binding site. Both Oct4λVP2 and Xlpou91λVP2 efficiently activated both reporters, whereas Oct4λEnR and Xlpou91λEnR repressed basal expression. The fusion proteins neither activated nor repressed transcription from a reporter lacking any PouV protein-responsive elements. λVP2 and λEnR had little activity when fused to Oct4V267P ([@bib35]) ([Figure S1](#figs1){ref-type="fig"}).

Activator Fusion Proteins Block Differentiation In Vivo {#sec2.2}
-------------------------------------------------------

We injected mRNA encoding Xlpou91, Xlpou91λEnR, or Xlpou91λVP2 into early *Xenopus* embryos and assessed, by in situ hybridization and RT-PCR, the expression of early lineage markers at gastrulation. We found that markers of early mesoderm and endoderm differentiation (Sox17, Mixer, and Goosecoid \[Gsc\]) were suppressed by Xlpou91 and Xlpou91λVP2 and were enhanced by Xlpou91λEnR. In contrast, the ventral marker BMP4, whose activity has been linked to ESC self-renewal ([@bib29; @bib53]), responded oppositely to these added factors ([Figures 1](#fig1){ref-type="fig"}A and [S2](#figs2){ref-type="fig"}A). The capacity of Xlpou91λEnR to induce the expression of differentiation markers implies that their induction is an indirect effect of inhibiting the PouV-supported network of undifferentiated gene expression.

Activator Fusion Proteins Rescue Oct4 Null ESCs {#sec2.3}
-----------------------------------------------

[Figure 1](#fig1){ref-type="fig"}B shows that exogenously added Xlpou91λVP2 and Oct4λVP2 maintained ZHBTc4 ESC growth in the absence of endogenous Oct4 (i.e., in the presence of Tc), whereas neither of the repressor fusions did so. The colonies depicted in the figure were generated by stable transfection of the ZHBTc4 ESCs with vectors expressing both the *Pac* gene (which renders cells resistant to puromycin) and one or another wild-type PouV proteins or PouV fusion protein under the control of the strong constitutive CAG promoter. The efficiency with which Oct4λVP2 supported Oct4 null ESCs (the rescue index, or normalized rescue efficiency) ([@bib35]) was equivalent to that obtained with wild-type Oct4. Although the rescue index for Xlpou91λVP2 was not as high as that obtained by Oct4λVP2, both proteins supported identical undifferentiated colony morphologies. Inspection of the rescued colonies suggests that Oct4λVP2 and Xlpou91λVP2 rendered the cells less likely to spontaneously differentiate than those rescued by wild-type Oct4 or Xlpou91. Thus, the latter displayed typical ESC colony morphology, with undifferentiated cells in the center and differentiated cells around the periphery ([Figure 1](#fig1){ref-type="fig"}C). In contrast, colonies rescued by the activator fusion proteins appeared undifferentiated throughout ([Figure 1](#fig1){ref-type="fig"}D). The mutant Oct4V267P, fused to either λVP2 or λEnR, was unable to support growth in the absence of Oct4 ([Figure S2](#figs2){ref-type="fig"}B). We also noted that colonies derived from stable transfection of ZHBTc4 with Oct4 or Xlpou91, in the absence of Tc, contained more differentiated cells than those in the presence of Tc ([Figure 1](#fig1){ref-type="fig"}C). This phenotype is consistent with the observation that overexpression (as well as underexpression) of Oct4 induces differentiation ([@bib34]). However, colonies derived from transfection of the activator forms of both proteins remained completely undifferentiated in the absence of Tc, a matter we return to below. Transfection of Oct4λEnR and Xlpou91λEnR into Oct4-expressing cells produced colonies composed largely of differentiated cells, as expected ([Figure 1](#fig1){ref-type="fig"}E). Similar completely undifferentiated colony morphologies were observed when Oct4λVP2 was introduced into the unrelated E14Tg2A ESC line ([Figure S2](#figs2){ref-type="fig"}C).

We further substantiated the rescue experiment just described by generating ZHBTc4 cell lines maintained by wild-type Oct4 and, separately, by Oct4λVP2 and by Xlpou91λVP2. Colonies like those in [Figures 1](#fig1){ref-type="fig"}C and 1D were expanded for at least five passages in the presence of constant puromycin and Tc. The Oct4λVP2- and Xlpou91λVP2-supported cultures had fewer differentiated cells than did those supported by wild-type Oct4 ([Figure S4](#figs4){ref-type="fig"}A). In both cases we examined multiple independent clonal cell lines to assure that ESC phenotypes were not the result of isolated karyotypic changes. As Oct4λVP2 and Xlpou91λVP2- expressing cell lines appeared identical, we focused on Oct4λVP2-supported cell lines. Four different Oct4λVP2-supported cell lines were also confirmed to have normal karyotypes (data not shown). We found that these cell lines self-renewed as efficiently as Oct4-supported lines, as assayed by assessment of the capacity of single cells to generate ESC colonies ([Figures S4](#figs4){ref-type="fig"}B and S4C). No difference in proliferation or plating efficiency was detected when these lines were compared to either ZHBTc4 or the unrelated ESC line E14Tg2A ([Figure S4](#figs4){ref-type="fig"}D). ESCs supported by Oct4λVP2, like ZHBTc4 and E14Tg2A cells, expressed the ESC transcription factors Nanog, Sox2, and Oct4 and the cell-surface markers *SSEA-1* and *E-cadherin* ([Figure 3](#fig3){ref-type="fig"}B, [S4](#figs4){ref-type="fig"}E, and S4F).

Activator Fusion Proteins Induce Pluripotency {#sec2.4}
---------------------------------------------

As noted in the [Introduction](#sec1){ref-type="sec"}, Oct4 is typically required, along with other transcription factors, to induce reprogramming of somatic cells to iPSCs in vitro. We tested the ability of various PouV-activator fusions and -repressor fusions to substitute for wild-type Oct4 in such a reprogramming experiment. We were able to generate both human and murine stable iPSCs by using activator, but not, where tested, repressor fusions ([Figures 2](#fig2){ref-type="fig"}A and 2B). The mouse iPSCs in [Figure 2](#fig2){ref-type="fig"}A were generated with the use of a single *piggy*Bac transposon that bears the *Sox2*, *Klf4*, and *c-Myc* genes, as well as either wild-type Oct 4 or Oct4**λ**VP2, all under control of a Tc-inducible promoter ([@bib20]). Although the timing of the appearance of ESC-like iPSC colonies after transfection and addition of the Tc analog Doxycycline (Dox) was comparable in the two cases, the Oct4λVP2 colonies grew faster than did their counterparts containing wild-type Oct4 ([Figure 2](#fig2){ref-type="fig"}A). The Oct4**λ**VP2-derived iPSC colonies were expanded in the presence of Dox. As expected for iPSCs, growth became independent of the exogenous genes, as indicated by growth in the absence of Dox ([Figures S5](#figs5){ref-type="fig"}A and S5B). When Oct4**λ**VP2-induced iPSCs were transplanted into adult mice, they formed teratomas containing derivatives of all three germ layers ([Figure S5](#figs5){ref-type="fig"}C), a further indication of pluripotency. To generate human iPSCs, we infected human fibroblasts with lentiviral vectors expressing the three additional factors (all human) plus either wild-type human OCT4 or OCT4 fusion proteins ([Figure S3](#figs3){ref-type="fig"}) ([@bib39]). [Figure 2](#fig2){ref-type="fig"}B shows that three OCT4-repressing fusions eliminated iPSC formation and that two activating fusions labeled "weak" and "medium" (see [Table 1](#tbl1){ref-type="table"} legend) substituted efficiently for wild-type OCT4. The activator fusion labeled "strong" worked somewhat less efficiently than did its weaker counterparts, but [Figure 2](#fig2){ref-type="fig"}C shows that decreasing its concentration improved its activity in this assay. Thus, Oct4-activator fusions, but not -repressor fusions, promote iPSC formation.

Gene Expression in Activator-Induced and -Maintained Pluripotent Cell Lines {#sec2.5}
---------------------------------------------------------------------------

### Murine ESC Lines {#sec2.5.1}

We used microarrays to compare the transcriptional profiles of ESCs maintained, respectively, by wild-type Oct4 and by Oct4λVP2. A set of genes directly or indirectly responsive to wild-type Oct4 was previously determined by measuring changes in gene expression after knockdown of endogenous Oct4 (by adding Tc to the parental ZHBTc4 ESCs) ([@bib46]). Putative direct targets of Oct4, from among these genes, were identified as being rapidly responsive and having at least one Oct4 binding site in the vicinity of the transcription start site on the basis of the ChIP-PET method. Of the 372 putative Oct4-dependent targets (from [@bib46]), some 94% were expressed at normal or higher levels in Oct4λVP2- maintained cells. Expression of the remaining 6% (23 genes) was reduced more than 2-fold ([Figure 3](#fig3){ref-type="fig"}A). Among these 23 there were only two genes with known pluripotency-related activity: *Sall4* and *Lefty1*. Most genes associated with differentiation (e.g., *Cdx2*, *Eomes*, *Fgf5*, *Gata6*, *Gata3*, *Igf2*, *Hand1*, *Esx1*) were either reduced or expressed at normal levels ([Table S1](#mmc1){ref-type="supplementary-material"}). All other pluripotency-related genes were expressed at either normal or higher levels in Oct4λVP2-rescued cells ([Table S1](#mmc1){ref-type="supplementary-material"}, [Figure 3](#fig3){ref-type="fig"}B; also see [Figure S7](#figs7){ref-type="fig"}), with a small set of primordial germ cell and pluripotency markers expressed at levels greater than 2-fold above wild-type cells, including *Gdf3*, *Dppa2*, *Dppa3* (*Stella*), *Eras*, *Tcfcp2l1*, *Id3*, *Fbxo15*, *Sox15*, and *Nanog*. Nanog was expressed at an average of 2- to 5-fold higher than in ordinary ESCs, and its distribution was more homogeneous ([Figure S4](#figs4){ref-type="fig"}E). Gene ontology (GO) annotations of the upregulated and downregulated genes in the Oct4λVP2 cell line with more than 2-fold changes are listed in [Table S2](#mmc2){ref-type="supplementary-material"}. While there does not appear to be a single biological process common to the upregulated genes in Oct4λVP2 cells, the downregulated gene set was enriched in functions associated with embryonic development and differentiation. These GO terms include a list of developmental transcription factors, cell differentiation, system development, epithelial differentiation, sex differentiation, cell migration, Wnt signaling, and several categories related to neural development.

### Murine and Human iPSC Lines {#sec2.5.2}

Endogenous pluripotency genes, including *Oct4*, *Klf4*, *Sox2*, and *c-Myc*, were expressed in murine iPSCs generated from fibroblasts with Oct4λVP2 (plus the other three factors) ([Figure 3](#fig3){ref-type="fig"}C, [Figure S5](#figs5){ref-type="fig"}). Expression of Nanog and Dppa4 at early times after transduction of human fibroblasts with OCT4 fusions was increased by increasingly stronger versions of OCT4-VP16 ([Figure 3](#fig3){ref-type="fig"}D). These markers were only modestly induced at this early time point by wild-type OCT4, and not at all by OCT4-HP1.

ESCs Rescued and Maintained by Activator Fusions Are Resistant to Differentiation {#sec2.6}
---------------------------------------------------------------------------------

Overexpression of Nanog has been reported to counter the induction of differentiation as a result of LIF removal ([@bib11]). Consistent with these findings, our Oct4λVP2-supported murine ESCs, which overexpress Nanog, are able to grow in the absence of LIF, as shown in [Figure 4](#fig4){ref-type="fig"}A. Oct4λVP2-maintained ESC lines were AP positive and exhibited undifferentiated ESC morphology when grown with or without LIF. These cells did, however, grow more slowly in the absence of LIF than in its presence ([Figure 4](#fig4){ref-type="fig"} and [Figures S6](#figs6){ref-type="fig"}B and S6C). To better understand the response of Oct4λVP2-supported cells to LIF, we compared mRNA from Oct4λVP2-rescued cell lines and two sets of control lines (Oct4-rescued and the parental ZHBTc4 cells) in response to LIF withdrawal ([Figures 4](#fig4){ref-type="fig"}B and 4C, [Table S3](#mmc3){ref-type="supplementary-material"}, and [Figure S6](#figs6){ref-type="fig"}). LIF withdrawal caused similar changes in gene expression in the latter two lines, with a single set of genes decreased (cluster a, [Figure 4](#fig4){ref-type="fig"}B) and a second set increased (cluster b, [Figure 4](#fig4){ref-type="fig"}B). However, LIF withdrawal from Oct4λVP2-maintained cell lines caused little change in expression of genes in either set. For example, expression of the pluripotency genes *Nanog*, *Klf4*, *Sox2*, and *Rex1* was downregulated in the control cells after LIF withdrawal, but their expression was unaffected in Oct4λVP2-maintained cells. The endodermal markers Gata4 and Gata6, upregulated upon LIF withdrawal from typical ESCs, remained unaffected by LIF withdrawal from Oct4λVP2-supported ESCs. Expression of certain mesoderm markers that are normally expressed alongside Oct4 in the primitive streak (e.g., Brachyury and Wnt 3) were increased after LIF removal from Oct4λVP2-supported cells ([Figure 4](#fig4){ref-type="fig"}C and [Figure S7](#figs7){ref-type="fig"}). When examined globally, there was a striking negative correlation between the set of genes that normally respond to LIF and those expressed at high levels in Oct4λVP2-maintained cells grown in the absence of LIF (comparison based on average log ratio, r = −0.695, t = 153, p \< 0.0001; also see [Figure S6](#figs6){ref-type="fig"}G).

Despite the robust expression of *Nanog* and other pluripotency-related genes in Oct4λVP2-maintained ESCs, and the conferred LIF independence just described, the expression of Oct4λVP2 itself was 2- to 5-fold lower than that of Oct4 in ESCs maintained by wild type Oct4 ([Figure 4](#fig4){ref-type="fig"}D, [Figure S4](#figs4){ref-type="fig"}E). We repeated the original Oct4λVP2-rescue experiment to generate new stable cell lines (see [Figure S4](#figs4){ref-type="fig"}A), adding the same amount of Tc to the medium but a reduced amount of puromycin. This reduced stringency of selection enabled the isolation of new Oct4λVP2-supported cell lines (Oct4λVP2^∗^), which expressed even lower levels (from 1.4- to 2-fold mRNA and/or protein) of Oct4λVP2 ([Figure 4](#fig4){ref-type="fig"}D). These lines also express correspondingly lower levels of Nanog and other pluripotency factors, similar to levels found in ESCs and in cells rescued by Oct4 ([Figure 4](#fig4){ref-type="fig"}D, [Figures S8](#figs8){ref-type="fig"}C and S8D). Upon removal of LIF, these cells differentiated to extents similar to those of wild-type Oct4-rescued ESCs and parental ZHBTc4 control cell lines ([Figure 4](#fig4){ref-type="fig"}E). Colonies generated from clonal growth of Oct4λVP2^∗^ cell lines appeared similar to wild-type Oct4-supported cell lines, both forming differentiated cells at the periphery ([Figures S8](#figs8){ref-type="fig"}A and S8B) and both sensitive to the differentiation-induced effect of Oct4 overexpression ([Figure 4](#fig4){ref-type="fig"}E).

Discussion {#sec3}
==========

Our findings support the idea that the necessary and sufficient action of Oct4 in inducing iPSC formation, and in blocking differentiation in vitro and in vivo, is to directly activate (rather than directly repress) expression of specific target genes. Thus, in both mouse ESCs and *Xenopus* embryos, PouV/Oct4-repressor fusion proteins induced differentiation, whereas the activator forms maintained the undifferentiated pluripotent state. Our results are consistent with a "positive only" model (based on a different line of experimentation) for maintenance of pluripotency of ESCs ([@bib10]).

Moreover, the Oct4-activator fusions, but not the -repressor fusions (along with additional transcription factors), induced iPSC formation. Analysis of gene expression profiles revealed that Oct4-activator fusions specifically enhanced expression of many genes identified as required for pluripotency, but not of genes that drive differentiation. One of our ESC lines (see below) maintains its ESC state even after withdrawal of LIF. These cells do not differentiate in response to additional Oct4 and thus do not display the usual Oct4 overexpression phenotype. These results are consistent with recent reports that claim enhanced efficiency in reprogramming as a result of the use of Oct4-VP16, Sox2-VP16, and Nanog-VP16 fusion proteins ([@bib50]) or Oct4-MyoD ([@bib18]).

We cannot exclude the possibility that Oct4 can repress certain genes, particularly in cases where it may bind cooperatively with other pluripotency factors with repression activity, and this might also explain its association with corepressor complexes. Such an activity, were it to exist, would not undermine the central finding of this paper, namely that activation and not repression is sufficient to induce and maintain the undifferentiated state. It is highly unlikely that our Oct4-VP16 fusion can repress certain genes as it activates others. The fusion activates two reporters bearing two different Oct4 DNA-recognition elements, both derived from natural enhancer elements. Moreover, we found that the activator fusion activated transcription of *Xist*, putatively a gene repressed by Oct4 in vivo ([@bib30]) ([Table S1](#mmc1){ref-type="supplementary-material"}). These and other observations indicate that the fusion protein Oct4λVP2 is likely an activator of all Oct4 targets, or at least of all those required for pluripotency.

Our work contrasts with the suggestion of [@bib25] that, in maintaining the ESC state, Oct4 attempts to drive differentiation along a specific path (see [Introduction](#sec1){ref-type="sec"}). It would also contradict the notion that an essential role of Oct4 in maintaining pluripotency is to directly repress genes required for differentiation ([@bib3; @bib4; @bib5; @bib12; @bib21; @bib26; @bib41]). It would, however, be consistent with the suggestion of [@bib54] that pluripotency is a "ground state" maintained by factors that prevent differentiation in response to (for example) paracrine signaling. Genes activated by Oct4 (and perhaps other pluripotency factors) would perform this function. This picture would cast pluripotency as another example of a "differentiated" state maintained by positive feedback. Thus, for other cases of terminal differentiation, an activator (or groups of self-reinforcing activators) maintains expression of its own gene as it activates expression of genes required for the differentiated state ([@bib19]). Oct4 is widely believed to maintain its own expression in a feedback loop involving, perhaps, other pluripotency gene regulators ([@bib13; @bib16; @bib46]). We found that increasing the activating region strength of the Oct4 fusions (bearing VP16 derivatives), as well as increasing the concentration of one of them, resulted in higher levels of Nanog expression, suggesting that Oct4 directly activates Nanog as part of this loop.

How, then, would we rationalize this proposal with findings and models of others? First, we note the importance attributed by [@bib25] to the finding that overexpression of Oct4 causes differentiation, a result taken to imply that Oct4 activates genes required for differentiation, not for pluripotency. But overexpression experiments can be difficult to interpret. An activator works in a concentration-dependent manner, binding to proper DNA sites (usually with other proteins) over a certain concentration range and then, at higher concentrations, binding less specifically to DNA. And, by virtue of protein-protein interactions, an overexpressed activator can inhibit (squelch) the effect of other activators and even its own action ([@bib15; @bib42]). Indeed, it has been reported that overexpression of Oct4 lacking a functional DNA-binding domain induces ESCs to differentiate ([@bib35]), a result indicating that the phenotype is not directly attributable to the ordinary action of Oct4.

In our experiments, any side effects of overexpression evidently have been eliminated by the use of the strong activator fusions. Thus, in a line of ESCs maintained by Oct4λVP2, the level of the Oct4λVP2 protein is low, significantly lower than that of wild-type Oct4 found in the typical ESC. These cells express high levels of select pluripotency factors, including Nanog, and are resistant to the ordinary inducing effect of differentiation upon LIF removal. These cells also, unlike ESCs maintained by exogenously added Oct4, do not differentiate when additional Oct4 is expressed. Another line, selected to express even lower levels of the activator, behaves like a typical ESC, subject to differentiation upon LIF removal, despite the very low level of expression of the activator fusion, and this line differentiates upon expression of additional Oct4.

Second, we note the importance given to genome-wide ChIP experiments showing that, in ESCs, Oct4 can be found bound to regulatory elements at certain genes that are not expressed---these genes become expressed upon differentiation. But lacking further analysis, these purported facts do not show that Oct4 is working as a repressor at those genes. Perhaps Oct4 is bound to genes in a nonfunctional state, awaiting relief from, or addition of, some partner to work. Polycomb, for example, is found at many silent genes in ESCs, but its removal has little effect on the maintenance of pluripotent gene expression ([@bib44]), and there are indications that polycomb remains at these genes during very early steps in differentiation (J.M.B. and W.A. Bickmore, unpublished data). There may be a misleading assumption at work here, namely that for a gene to be "off" it must be actively repressed. Though this is true for most genes in bacteria, it is not true in general for genes in eukaryotes. In bacteria, specific repressors are required to eliminate an otherwise significant basal level expression upon removal of activators, but this is evidently not true for eukaryotic genes. Rather, it seems, the general inhibiting effect of nucleosomes maintains basal expression at very low levels ([@bib48; @bib57]). Thus, without activators that would turn on the differentiation genes, there would be no need for repressors to turn them off. And so in ESCs, where activators maintain expression of pluripotency genes, differentiation genes could simply be off (by default, as it were) until activated by some activators that are rendered functional by virtue of gain (or loss) of a signal.

Experimental Procedures {#sec4}
=======================

ESCs were cultured on 0.1% gelatin-coated flasks or plates (IWAKI) in Glasgow modified Eagle\'s medium (GIBCO) containing nonessential amino acids, glutamine, sodium pyruvate, 0.1 mM mercaptoethanol, 10% fetal calf serum (FCS), and LIF as described previously ([@bib24; @bib29]). LIF withdrawal and Oct4 overexpression was performed according to [@bib29]. For ESC self-renewal rescue experiments, 2 × 10^7^ ZHBTc4 ESCs were electroporated with 100 μg of linearized plasmid DNA followed by culture with or without 2 μg/ml Tc (Sigma) for 2 days. Cells were then cultured in 2 μg/ml puromycin (Sigma) with or without Tc for 7 days. The resulting colonies were stained for alkaline phosphatase (AP) activity (Sigma-Aldrich) or expanded as clonal lines ([@bib29]). The cDNAs used for ESC rescue were inserted into pCAGIP vector ([@bib35; @bib32]).

Luciferase assays were performed as described previously ([@bib7; @bib29]). ZHBTc4 ESCs (1 × 10^5^) were plated on a 24-well plate with 2 μg/ml of Tc. Twenty-four hours after plating, the reporter and test plasmid were transfected with the use of Lipofactamine 2000 (Invitrogen). Twenty-four to forty-eight hours after transfection, the cells were collected and lysed, and luciferase assay was performed with the Dual-Luciferase Reporter Assay System (Promega). Reporter plasmids were a kind gift from Professor Hitoshi Niwa (Riken Institute, Japan) ([@bib35]). The expression vector used was the pCAG-IP plasmid.

Growth rates were assessed in 96-well plates with CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega). A total of 1,000 cells were plated per well and assayed every 24 hr according to the manufacturer\'s instructions. AP staining was performed with the Leukocyte Alkaline Phosphatase Assay Kit (Sigma).

For antibody staining, cells were washed twice in PBS, followed by fixation in 4% paraformaldehyde. Cells were then permeabilized in PBS + 0.1% Tween 20 (PBST), and blocking was performed by adding 1% bovine serum albumin (BSA) (Sigma) PBST to the cells for 30 min at room temperature. Primary antibodies (see [Table S4](#mmc4){ref-type="supplementary-material"} for details) were incubated overnight at 4°C, followed by three washes in PBST for 10 min each. Alexa Fluor-conjugated secondary antibodies (see [Table S4](#mmc4){ref-type="supplementary-material"} for details) were diluted in blocking solution and added to the cells for 3 hr at room temperature with the DAPI solution. Finally, cells were washed three times in PBST.

Flow cytometry was used to analyze the percentage of ESC clones expressing the cell-surface markers SSEA1 and E-Cadherin (for the antibodies, see [Table S4](#mmc4){ref-type="supplementary-material"}). Cells were collected into the cell-dissociation buffer (GIBCO) and incubated at 37°C for 10 min. Single-cell suspension was achieved by gentle repeated pipetting. After PBS washes, cells were resuspended in 500 μl FACS buffer (1× PBS and 10% FCS). To mark apoptotic cells, 5 μl/10^6^ cells of 7AAD solution (BD PharMingen) was added to cells. Samples were analyzed in a FACSCalibur flow cytometer (BD Biosciences). Data were analyzed with the Cell Quest software (BD Biosciences).

For qRT-PCR analysis, total RNA was prepared from cells with the use of Trizol reagent (Invitrogen). RNA (0.5--1 μg) was used as a template for cDNA synthesis with the use of Superscript III (Invitrogen). qRT-PCR was performed with the use of a LightCycler 480 (Roche). Primers and PCR conditions are listed in [Table S5](#mmc5){ref-type="supplementary-material"}.

Embryo injection, culture, and in situ hybridization were described in [@bib56] and [@bib29]. To generate RNA for injections, pCS2+ plasmids harboring the target cDNAs *Xlpou91λVP2*, *Oct4λVP2*, *Xlpou91λEnR*, *Oct4λEnR*, *Oct4*, and *Xlpou91* were linearized with *BssHI*I and used as a template for RNA synthesis with SP6 polymerase (Promega). Total RNA was prepared from five embryos with the RNeasy Mini Kit (QIAGEN) and DNase1 treatment. RNA (500 ng) was used as a template for cDNA synthesis with Superscript III (QIAGEN). Real-time PCR was carried out with a Lightcycler 480 (Roche). Real-time PCR primers are listed in [Table S5](#mmc5){ref-type="supplementary-material"}.

For microarray analysis, two independent clones from each cell line were used as biological replications. Cy3-CTP-labeled sample targets were prepared from 2.5 μg of total RNA with the use of a Low RNA Input Fluorescent Linear Amplification Kit (Agilent). Cy5-CTP-labeled reference target was produced from 2.5 μg of Stratagene Universal Mouse Reference RNA. Purified target RNAs were hybridized to the NIA Mouse 44K Microarray version 3.0 (whole-genome 60-mer oligo arrays, Agilent Technology, design ID 015087) ([@bib9]) according to the manufacturer\'s protocol (Two-Color Microarray-Based Gene Expression Analysis Protocol, version 5.0.1). Data were analyzed via NIA Array Analysis ([@bib45]) under standard statistical conditions (FDR \< 0.05, 2-fold expression level change).

For mouse iPSC generation, *Piggy*Bac transposons containing *Oct4* and *Oct4λVP2* were constructed as described previously ([@bib20]). Mouse embryonic fibroblasts (MEFs) were isolated from 13.5 dpc (days postcoitus) ROSA26 knockin rtTA-IRES-GFP embryos. MEF Nucleofector Kit 2 (Amaxa) and program T-20 were used for nucleofection. A total of 2 × 10^6^ cells were transfected, and 5 × 10^5^ cells were seeded on gelatine in 10 cm^2^ dishes. Cells were cultured in ESC media supplemented with 1.5 ug of Dox. Colonies arising after transfection were picked at day 24, trypsinized, and replated on gelatine. Dox was removed from the culture after several passages.

Lentiviral vector production, human iPSC generation, and immunostaining were performed as previously described ([@bib39]). Separate lentiviral constructs encoding full-length human Oct4, Sox2, Klf4, and cMyc linked by a P2A peptide to vexGFP, mCitrine, mCherry, and mCerulean, respectively, were used. MRC-5 human embryonic fibroblasts (American Type Culture Collection \[ATCC\]) were transduced with supernatants of the four lentiviral vectors in the presence of 4 μg/ml polybrene for approximately 16 hr. Three days after transduction, the cells were plated at a density of 20,000 cells per 60 mm dish on a feeder layer of mitomycin-C-treated MEFs. Analysis of the four vector-encoded transcription factors\' expression by flow cytometry 3 days after transduction was used to identify groups with similar expression levels (mean fluorescence intensity) for comparison. The next day, the medium was switched to hESC medium supplemented with 6 ng/mL FGF2 and was replaced every day thereafter. Then, 16-18 days after transduction, colonies with hESC morphology were mechanically dissociated and transferred into 24-well plates on MEFs. Cells were thereafter passaged with dispase and expanded to establish hiPSC lines.

Accession Numbers {#app1}
=================

The GEO accession number for the microarray data reported in this paper is GSE24563.
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Table S1. Comparison of Gene Expression Changes in Response to Oct4 and Oct4λVP2, Related to Figure 3Gene expression was measured at 24 h after depletion of Oct4 and compared to the expression difference between Oct4-λVP2 or normal Oct4 rescued ZHBTc4 ESCs. Values listed in this table are relevant to Figure 3ATable S2. Gene Ontology of Upregulated and Downregulated Genes in Oct4λVP2 Cell Line, Related to Figure 3Gene ontology (GO) annotations of upregulated and downregulated genes in Oct4λVP2 cell line in comparison to control cell lines with more than 2 fold change. Categories with enrichment \< 2, FDR \< 0.05 or contain less than 5 genes are not shownTable S3. List of Genes with Significant Changes in Expression during LIF Withdrawal, Related to Figure 4Comparison of gene expression changes between Oct4, Oct4λVP2 rescued cell lines and ZHBTc4 ESCs during LIF withdrawal (FDR \< 0.05 and \> 2-fold). Data used in Figures 4 and S6.Table S4. List of Antibodies, Related to Figures 5, 7, and S4The table lists the source and working dilution for each antibody used for Western blotting (WB), Immunofluorescence (IF), and Fluorescence-activated cell sorting (FACS).Table S5. List of qRT-PCR Primers, Related to Figures 3, 4, 5, 6, 7, 8, and S2The table lists the sequence and the qRT-PCR condition for each primer sets used. qRT-PCR was performed using LightCycler FastStart DNA Master^PLUS^ SYBR Green1 (SYBR) or universal probe library (UPL) mix from Roche.Document S1. Article plus Supplemental Information
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![Actions of PouV-Activator and -Repressor Proteins\
(A) In situ assays for the mRNA products of Mixer, Sox17, and BMP4 were performed on stage 10.25 embryos after injection of Xlpou91, Xlpou91**λ**VP2, or Xlpou91**λ**EnR mRNA at the two-cell stage into both blastomeres. The images are from the vegetal pole (top two rows) and the animal pole (bottom row).\
(B) The relative numbers of cells rescued by the indicated regulators is shown as the rescue index. Each transfection was divided, and half the cells were plated in the presence of Tc and the rest in its absence. The rescue index was calculated by dividing the number of alkaline phosphatase (AP)-positive colonies obtained in the absence and presence of Oct4 (± Tc). Data represent the mean values obtained from three independent experiments.\
(C--E) Morphology of ESC colonies supported by wild-type PouV proteins (C), activator fusions (D), and repressor fusions (E). The colonies were generated by stable transfection of the ZHBTc4 ESCs with vectors expressing one or another wild-type PouV or PouV fusion proteins and the *Pac* gene (which renders cells puromycin resistant) from an internal ribosome entry site (IRES) in the same message, all under the control of the strong CAG promoter. Constitutive expression of the exogenous fusion proteins in the absence of Oct4 was selected on the basis of Puromycin resistance in the presence of Tc. Cultures were stained for AP (red).](gr1){#fig1}

![Oct4-Activator Fusions Support iPSC Generation\
(A) Morphology of colonies resulting from mouse embryonic fibroblasts (MEF) transfection with either wild-type Oct4 or Oct4λVP2 alongside the other reprogramming factors (cMyc, Klf4, and Sox2) at days 5, 9, 18, and 24 after transfection in the presence of the Tc analog Dox. MEFs were transfected with a *piggy*Bac transposon bearing a single-message multigene expression cassette under the control of a Tc-inducible promoter.\
(B) OCT4 activator fusions support human iPSC generation. MRC-5 human embryonic fibroblasts were transduced with combinations of four lentiviral bicistronic vectors coexpressing each reprogramming factor, linked by a P2A peptide, to a fluorescent protein ([@bib39]): SOX2 together with mCitrine, KLF4 with mCherry, cMYC with mCerulean, and either wild-type OCT4 or OCT4 fusion proteins with vexGFP. The efficiency was calculated with the use of the experimental setup depicted in [Figure S3](#figs3){ref-type="fig"}C. In brief, the number of Tra-1-81^+^ colonies (scored by immunostaining on day 15 after transduction) per number of plated cells divided by the fraction of quadruple positive cells as estimated by flow cytometry on day 2 after transduction.\
(C) Lower levels of the strong activator (OCT4-VP16 \[3F\]) work more efficiently in iPSC formation. MRC-5 human embryonic fibroblasts were transduced as in (B) with the use of 3-fold titrations of the vector expressing either wild-type OCT4 or OCT4-VP16 (3F) and constant amounts of the other three vectors (SOX2, KLF4, cMYC). The reprogramming efficiency was calculated as in (B). See also [Figure S3](#figs3){ref-type="fig"}C and its associated legend.](gr2){#fig2}

![Oct4 Activator Fusions Induce and Maintain the Expression of Pluripotency-Related Genes\
(A) Oct4λVP2 enhances the expression of Oct4-positively-regulated genes and inhibits the expression of those genes negatively regulated by Oct4.\
We compared the total set of genes changing when Oct4λVP2-supported cells were compared to controls, to the complete set of genes responsive to Oct4. The majority of these genes (94%) were expressed at normal (around the *x* axis) or higher than normal (above the *x* axis) levels in Oct4λVP2 cells. The basis for this plot was the difference between the log expression of genes in Oct4λVP2 cells and the average log expression in both controls, plotted against the maximum gene expression change (log ratio) in a time course after *Oct4-Tc* silencing (addition of Tc) in ZHBTc4 ESCs (the time course data from [@bib46]). Genes with \< 1.5-fold change of expression after *Oct4-Tc* silencing are not shown. Oct4-dependent genes that also contain Oct4, Nanog, and Sox2 binding sites are indicated as targets (light blue or purple; see [@bib46]).\
(B) Expression of pluripotency genes in Oct4λVP2-rescued cells. Expression levels of pluripotency-related genes including *Nanog*, *Sox2*, *Klf4*, and *Rex1* were determined by qRT-PCR. Expression levels of all analyzed genes were normalized to *TBP* levels for each sample.\
(C) iPSCs generated with the use of Oct4λVP2 express levels of pluripotency markers similar to those of normal iPSCs. Expression levels of a range of pluripotent cell markers were assessed by qRT-PCR. *Nanog, Fgf4*, *Rex1*, *Dppa4*, and *Eras* expression is shown in wild-type Oct4 and Oct4λVP2 iPSCs. Duplicate bars represent independent iPSC lines. Expression levels were normalized to *TBP* levels for each sample. Key indicates the Oct4 protein used for reprogramming. E14 (embryonic day 14) Tg2A ESCs and MEFs were used for the sake of comparison.\
(D) Wild-type OCT4 and its activator fusions, but not OCT4-HP1 repressor fusions, induce immediate early expression of pluripotency markers, *NANOG* and *DPPA4*. MRC5 human embryonic fibroblast cells were harvested 48 hr after viral transduction for mRNA analysis. Expression levels in an iPSC line generated with the use of wild-type forms of all four factors are shown for comparison. Levels of gene expression are relative to RPL7 and normalized to nontransduced control.](gr3){#fig3}

![Differential Effect of Oct4λVP2 Dose on ESC Differentiation\
(A) Oct4λVP2 maintains undifferentiated phenotypes irrespective of the presence of LIF or additional Oct4. Oct4λVP2-supported and control ESC lines were plated in the absence of LIF or absence of Tc (Oct4 overexpression) for 5 days. Cultures were stained for AP (red).\
(B) Changes in gene expression normally associated with LIF withdrawal do not occur in Oct4λVP2-supported cells. Here, a heat map shows the 3,000 genes with the most significant differences in gene expression after LIF withdrawal. Two clusters are bracketed by "a" and "b": a, genes that are downregulated in Oct4 and ZHBTc4 cells, but not in Oct4λVP2 cells, after 120 hr of LIF withdrawal; b, genes that are upregulated in Oct4 and ZHBTc4 cells, but not in Oct4λVP2 cells, after 120 hr of LIF withdrawal.\
(C) Pluripotency genes are supported in the absence of LIF in Oct4λVP2 cells. Shown are plots comparing mean log intensity values of representative pluripotency genes. Error bars represent SD between expression levels in two independent clones.\
(D) Oct4λVP2^∗^ cells compared to original Oct4λVP2 and control cell lines. These cells, generated in reduced puromycin, express reduced levels of Oct4λVP2 and Nanog. Western blots comparing expression levels of Oct4 and Nanog in the different rescued cell lines are shown.\
(E) Oct4λVP2^∗^ cell lines differentiate in response to LIF withdrawal and Oct4 overexpression. Cells were plated at clonal density in the absence of LIF or Oct4 overexpression for 5 days. Two clones for each cell line except ZHBTc4 were used and stained for AP activity (red). Representative colonies are shown for each condition.](gr4){#fig4}

![Transcriptional Activity of Oct4 and Xlpou91 Fusion Proteins, Related to [Table 1](#tbl1){ref-type="table"}\
(A) Activity of Oct4 and Xlpou91, λVP2 and λEnR fusion proteins on different reporter genes. Different octamer recognition sites are positioned upstream of the minimal *thymidine kinase (TK)* promoter driving luciferase. The reiterated octamer reporter contains 6 copies of the octamer-binding motif derived from the mouse immunoglobulin heavy gene enhancer and the Fgf4 reporter contains the 460 bp enhancer region that includes both Sox2 and Oct4 binding sites. Co-transfection of activator fusions alongside these reporters in ZHBTc4 ESCs lead to induction of luciferase, whereas the repressor fusions suppress the basal level of the TK promoter. None of the tested fusions had any activity on a reporter lacking octamer recognition elements.\
(B) DNA-binding deficient Oct4V267P fusions to either λVP2 or λEnR had no activity on any of the reporters tested in A. All transfections were done 24 hr following the plating of ZHBTc4 ESCs in the presence of Tc. This is to insure that all Oct4 activity originates from the exogenous expression vectors. Fold induction represents the increase in reporter transcription compared with the control. Data represent the mean value of two independent experiments.](figs1){#figs1}

![PouV Activator Proteins, but Not DNA Binding Mutants, Support the Undifferentiated State, Related to [Figure 1](#fig1){ref-type="fig"}\
(A) qRT-PCR quantification of *Gsc* and *BMP4* RNA levels in response to PouV fusion protein overexpression in *Xenopus* embryos. Total RNA was collected from stage 10.25 embryos following injection of mRNA encoding PouV fusion proteins at the two cell stage. Gene expression levels were normalized to those from the control embryos.\
(B) Oct4V267P, Oct4V267PλVP2 and Oct4V267PλEnR do not support undifferentiated colony formation in the absence of Oct4. ZHBTc4 ESCs were transfected with vectors expressing the indicated PouV fusion under the control of the CAG promoter in the presence of Tc. Plates were stained with alkaline phosphatase (AP) ten days following transfection and representative colonies are shown.\
(C) Overexpression of Oct4λVP2 in wild-type E14Tg2A ESCs. Undifferentiated colony morphologies were observed when Oct4λVP2 was introduced into the E14Tg2A ESC line, despite the presence of endogeneous Oct4. These colonies are morphologically similar to those obtained from transfection of the ZHBTc4 ESCs with PouV activator proteins in the absence of Tc. E14Tg2A ESCs were transfected with vectors expressing the indicated proteins under the control of the CAG promoter. Plates were stained with AP ten days following transfection and representative colonies are shown.](figs2){#figs2}

![The Approach to iPSC Generation in Both Mouse and Human Cells, Related to [Figure 2](#fig2){ref-type="fig"}\
(A) Schematic diagram of the strategy used to generate mouse iPSCs from mouse embryonic fibroblasts (MEFs) using Oct4λVP2 in place of Oct4. MEFs were derived from mice carrying rtTA in the Rosa26 locus and were transfected with *piggy*Bac transposon containing *c-Myc, Klf4, Sox2* and either wild-type *Oct4* or *Oct4λVP2* expressed from a single transcript. Transfected cells were cultured in the presence of doxycycline (Dox) to induce the expression of the four factors. Colonies were picked 24 days after transfection and expanded.\
(B) Diagram depicting the construction of the human OCT4 activator and repressor forms. Separate lentiviral constructs encoding full length human OCT4, SOX2, KLF4 and c-MYC that are linked by a P2A peptide to vexGFP, mCitrine, mCherry and mCerulean, respectively, were used. Activator forms of OCT4 were generated by fusing its C terminus to different versions of the VP16 activation domain: a weak VP16 fusion (425-455aa), a medium strength VP16 (425-490aa) and a strong VP16 ('3F'; 3 tandem repeats of PADALDDFDLDML). Repressor fusions of OCT4 were made by fusing full length HP1α, HP1β or HP1γ to the C terminus of OCT4.\
(C) Schematic diagram of the strategy used to generate iPSCs using OCT4 activator and repressor forms from human embryonic fibroblast (MRC-5) (from ATCC). MRC-5 were transduced with supernatants of the four lentiviral vectors. In order to achieve accurate comparisons for reprogramming efficiency, flow cytometry was used three days following transfection to identify cells with similar expression levels of the four factors.\
The experiment shown in [Figure 2](#fig2){ref-type="fig"}C was performed as follows: MRC-5 were transduced with wild-type OCT4 or OCT4-VP16 at 3 different multiplicities of infection (MOIs) for each vector. Flow cytometry was used to measure expression of OCT4 (by means of measuring the mean fluorescence intensity (MFI) of vexGFP co-expressed stoichiometrically with OCT4 or OCT4-VP16 through a P2A peptide). In order to control for levels of expression - so that the differences in reprogramming efficiency can only be attributed to the presence versus absence of the VP16 domain - MFI was converted to arbitrary units and depicted as "relative OCT4 expression" (*x* axis). Higher OCT4-VP16 expression (corresponding to 3x arbitrary units) was not experimentally feasible, as it resulted in excessive cell death immediately after (within 48h) transduction (vector-mediated toxicity, possibly attributable to VSVG capsid protein toxicity used for lentiviral vector packaging).](figs3){#figs3}

![Characterization of PouV Activator-Rescued ESC Lines, Related to [Figure 3](#fig3){ref-type="fig"}\
(A) The derivation of clonal ESC lines supported by Oct4λVP2 and Xlpou91λVP2 in place of Oct4. Following the electroporation of *Oct4λVP2* and *Xlpou91λVP2* constructs in ZHBTc4 cells, puromycin selection was applied for nine days in the presence of Tc (*-Oct4*). The rescued colonies were then picked and expanded under the same conditions. The figure (right hand panel) shows the morphology of Oct4λVP2 and Xlpou91λVP2 expressing cell lines at passage 5 (p5) in the presence of continued Tc, compared to the morphology obtained as a result of expansion in the presence of Oct4 expressed from the Tc regulatable transgene (+Oct4)\
(B) Oct4λVP2 supports ESC clonal self-renewal at similar levels to wild-type Oct4 in the presence of LIF and serum. The indicated cell lines were plated at clonal density (60 cells/cm2), and cultured for 6 days under standard self-renewal conditions (LIF and serum) then stained for AP (red). The figure shows examples of the colony morphology present in each cell line.\
(C) Oct4λVP2-supported cell lines give rise to completely undifferentiated colonies at a similar frequency as control ESC lines. Colonies were classified into three categories: Uniformly AP positive undifferentiated colonies, mixed colonies containing AP positive and negative cells, and AP negative differentiated colonies. Data represents average values from two independent clones for each cell line.\
(D) Oct4λVP2 rescued cell lines proliferate at a similar rate to wild-type and control (Oct4 rescued ZHBTc4) ESCs. Cell growth was measured by an MTS assay and is plotted on the *y*-axis against time (days) on the *x*-axis. Data represent one of two experiments in which each data point was performed in triplicate.\
(E) Oct4λVP2 supported ESC lines have increased Nanog and normal Sox2 expression, despite reduced levels of Oct4λVP2. The figure depicts typical images based on data from three independent clones of activator supported cell lines cultured under standard ESC self-renewal conditions (Serum and LIF) and immunostained for Oct4, Nanog and Sox2 proteins. DAPI staining is shown for each cell line and antibody.\
(F) Oct4λVP2 supported cell lines express normal levels of ESC associated cell surface markers SSEA-1 and E-cadherin. The figure shows representative data from one of three independent clones of Oct4λVP2 and Oct4 cell lines that were grown under self-renewal conditions (serum and LIF) and subjected to analysis by flow cytometry for SSEA-1 and E-cadherin. ZHBTc4 and E14Tg2A cell lines were used as positive controls.\
(G) Expression of differentiation genes in Oct4λVP2 rescued cells. Expression of differentiation-related genes was measured by qRT-PCR. Expression levels of all analyzed genes were normalized to *TBP* levels.](figs4){#figs4}

![Characterization of Mouse iPSC Lines Generated Using Either Oct4 or Oct4λVP2, Related to [Figure 3](#fig3){ref-type="fig"}\
(A) Expression of Oct4, Nanog and Sox2 in iPSCs generated by reprogramming with either Oct4 or Oct4λVP2. Expanded wild type Oct4 and Oct4λVP2 iPSC-lines were cultured in the absence of Dox (absence of the original exogenous reprogramming factors) and factor independent expression of endogenous Oct4 and Sox2 as well as Nanog was confirmed by immunofluorescence. DAPI nuclear staining (blue field) images are shown for each antibody staining.\
(B) Reactivation of the endogenous transcripts for pluripotency genes in Oct4λVP2 iPSCs. Cells were cultured under self-renewal conditions and RNA was collected for qRT-PCR. The expression levels of the endogenous *Klf4*, *Oct4*, *Sox2* and *c-Myc* and a number of other pluripotency markers are shown.\
(C) iPSCs generated by Oct4λVP2 are pluripotent. Cells were subcutaneously transplanted into nude mice. After 4 weeks, tumors were sectioned and stained with hematoxylin and eosin staining. Tumours contained EC cells, differentiated neural tissue, immature neurons, muscle tissue, cartilage, bone, endoderm tissue, pulmonary epithelium (PE) and keratinised epithelium (KW).](figs5){#figs5}

![Oct4λVP2 Supports Self-Renewal under Differentiation Inducing Conditions, Related to [Figure 4](#fig4){ref-type="fig"}\
(A) Oct4λVP2 supports clonal self-renewal in the absence of LIF or presence of additional Oct4. The indicated cell lines were plated at clonal density in the presence or absence of LIF or the presence of Oct4 overexpression for 5 days and colonies stained with AP. While the Oct4λVP2 colonies are small, they remain AP positive.\
(B) Slow growing Oct4λVP2-supported cells in the absence of LIF form phenotypically normal ES colonies when allowed to grow for longer periods. ESC colonies derived from Oct4λVP2-supported cell lines were allowed to grow for 15 days in the absence of LIF and were stained with AP.\
(C) Quantitative analysis of LIF independent undifferentiated growth observed in Oct4λVP2-supported ESCs. Colonies were classified into three categories after 15 days of LIF independent growth: Uniformly AP positive undifferentiated colonies, mixed colonies containing AP positive and negative cells, and AP negative differentiated colonies. In the case of Oct4λVP2 cell lines, colonies were classified into AP positive undifferentiated normal size and small colonies. Data represents average values from two independent clones from each cell line.\
(D) Total Oct4 and Oct4λVP2 expression levels observed after reactivation of Tc regulatable Oct4 transgene. RNA was collected at day 5 of the differentiation experiments for qRT-PCR analysis. Levels of Oct4 expression are relative to *TBP*.\
(E) Schematic representation of the experimental design and micro-array time points used to assess global gene expression during LIF withdrawal. Oct4λVP2 cells and control cell lines were plated at low density under self-renewing conditions for 24 hr and RNA collected at this time point. The medium was then changed to medium without LIF and cells were allowed to differentiate. RNA was collected after 48h and 120h. Two clones from each cell line were used as biological replicates.\
(F**)** Venn diagrams showing that only a minority of differentiation specific genes are upregulated in Oct4λVP2 cells during LIF withdrawal and only a minority of the ESC gene-expression set normally downregulated during LIF withdrawal is affected in Oct4λVP2 cells.\
(G) Genes normally regulated by LIF withdrawal correlate very well with genes upregulated in Oct4λVP2-supported ESCs in the absence of LIF. The plot compares the effect of LIF withdrawal on gene expression after 120 hr of differentiation to the gene expression differences between Oct4λVP2 cells and control cells at this same time point. There is a strong negative correlation (r = −0.695, t = 153, p \< 0.0001) between the average log ratio of LIF withdrawal effects in control cells and the difference in gene expression between Oct4λVP2-rescued cells and control cells.](figs6){#figs6}

![Oct4λVP2 Supported ESCs Retain Significant Pluripotent Character in LIF Withdrawal, Related to [Figure 4](#fig4){ref-type="fig"}\
Gene expression in Oct4λVP2 supported cells during LIF withdrawal was assessed by qRT-PCR. Total RNA was collected during the LIF withdrawal time course. qRT-PCR was used to assess the expression of key pluripotency, mesoderm and endoderm genes in Oct4λVP2 cells during LIF withdrawal. Duplicates bars in each condition represent independent clones. Expression levels were normalized to TBP levels.](figs7){#figs7}

![Cell Lines Supported by Reduced Levels of Oct4λVP2 Have a Normal ESC Phenotype, Related to [Figure 4](#fig4){ref-type="fig"}\
(A) Examples of colony morphology present in each cell line. Oct4λVP2^∗^ cell lines derived in lower levels of puromycin contain differentiated cells at the periphery. The indicated cell lines were plated at clonal density (60 cells/cm^2^), and cultured for 6 days in self-renewal conditions then stained for AP activity (red).\
(B) Quantification of self-renewal and differentiation rates in Oct4λVP2 versus Oct4λVP2^∗^ cell lines. Colonies were classified into three categories: Uniformly AP positive undifferentiated colonies, mixed colonies containing AP positive and negative cells, and AP negative differentiated colonies. The percentages of the different colony categories present in each cell line are shown. Data represents average values from two independent clones from each cell line.\
(C) Oct4λVP2^∗^ cell lines derived in lower levels of puromycin express lower levels of the Oct4λVP2 transgene and some pluripotency markers when compared to the original Oct4λVP2 cell line. Two clones from each cell line (except ZHBTc4) cultured under self-renewal conditions were fixed and immunostained for Oct4, Nanog and Sox2 proteins. Representative images are shown. DAPI nuclear staining (blue field) is shown alongside each antibody staining.\
(D) Expression of key pluripotency network members in Oct4λVP2^∗^ cells. RNA from two independent clones was subjected to qRT-PCR analysis of expression levels of pluripotency markers and trophoblast differentiation marker Cdx2. Expression levels of all analyzed genes were normalized to *TBP* levels.](figs8){#figs8}

###### 

PouV Fusion Proteins

  Fusion Protein   PouV Protein   Hinge            Transcriptional Regulatory Region   Repeats
  ---------------- -------------- ---------------- ----------------------------------- ---------
  Oct4λVP2         mOct4          λ C1 (91--132)   VP16 (413--460)                     2
  XlPou91λVP2      XlPou91        λ C1 (91--132)   VP16 (413--460)                     2
  OCT4-VP16        hOCT4          \-               VP16 (425--455)                     1
  OCT4-VP16        hOCT4          \-               VP16 (425--490)                     1
  OCT4-VP16 (3F)   hOCT4          \-               VP16 (PADALDDFDLDML)                3
  Oct4λEnR         mOct4          λ C1 (91--132)   EnR (168--281)                      1
  XlPou91λEnR      XlPou91        λ C1 (91--132)   EnR (168--281)                      1
  OCT4-HP1α        hOCT4          \-               HP1α                                1
  OCT4-HP1β        hOCT4          \-               HP1β                                1
  OCT4-HP1γ        hOCT4          \-               HP1γ                                1

The human and mouse Oct4 genes and the *Xenopus* homolog XlPou91 were variously fused to one or more activating regions from VP16, to a repressing region from the *Drosophila* Engrailed protein, and to one of each of the three intact isoforms of the human protein HP1. In some cases a sequence encoding a hinge region in lambda repressor c1 was inserted between Oct4 or XlPou91, added regulatory sequences, and repeated regulatory modules ([@bib36]). PADALDDFDLDML is a single amino acid variant of an activating sequence found in VP16 ([@bib2]). "Repeats" indicate the number of copies of the activation region in the corresponding fusion. The three OCT4-VP16 activation fusions are listed in the order of their presumed activation strengths, referred to in the text as "weak," "medium," and "strong." Abbreviations are as follows: m, murine; h, human; Xl, *Xenopus laevis*.
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